WELCOME TO The Biotechnology REPORT
Dialogue / Advancing Meaningful Patient Engagement in Research, Development, and Review of Drugs
September 22, 2015
I'm For Real
Enter your details once to access all our information and resources
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.
whitePaper | November 14, 2019
SmartExtraction significantly simplifies the entire automated workflow of DNA extraction, setting new standards with regard to efficiency, yield and quality of the DNA.
whitePaper | May 20, 2022
We are living in a unique time in which the world is changing faster than ever. This largely is due to an influx and infusion of digital technologies that are reinventing and reimagining businesses across nearly every sector, and dramatically shifting societal and economic interactions. While the life science industry has, to some extent, adopted various digital technologies, it has not had a significant digital transformation in how it does business.
whitePaper | September 17, 2021
The adoption of CAR T therapies in the UK NHS is a success story, especially seen in
relation to the experience in many other countries. The UK NHS showed itself to be agile,
and responsive to addressing the unique challenges these therapies present, which
facilitated access to patients earlier than in many other countries. (including delivery centre
selection, development of service specifications, collaboration with manufacturers
throughout the preparation phase for adoption, establishment of national multidisciplinary
CAR T team to ensure equity of access and prioritization of resources (where needed)).
whitePaper | February 2, 2022
While many sectors were dealt a severe blow by the COVID-19pandemic, biotech and medtech saw continued growth andare thus attracting top candidates even for non-scientific roles.
whitePaper | April 14, 2020
Your vision is to create revolutionary cell and gene therapies to treat life threatening diseases. Bio-Techne and its family of brands is on this journey with you. As a full-solution ancillary reagent and services provider, we will stand by you, providing flexible and pioneering tools to simplify your workflow. From CAR T cells to pluripotent stem cells, let us help you get your therapy to the patients that need it
whitePaper | February 11, 2022
The biomanufacturing revolution is here. Recent
advancements in the field of synthetic biology
have enabled significant cost reductions in
foundational bioengineering unit operations such
as DNA synthesis and sequencing.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE